151. Ninjurin 1 gene asp110ala genetic variants as a susceptibility factor in nerve damage leprosy patients of India
- Author
-
Kavitha Hemachandran, Abilash Valsala Gopalakrishnan, Chandirasekar Ramachandran, Vimala Karuppaiya, Sasikala Keshavarao, Calistus Jude Al, and Arun Sundaramoorthy
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,biology ,biology.organism_classification ,medicine.disease ,law.invention ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,law ,Peripheral nervous system ,Genotype ,Genetic variation ,Immunology ,Genetics ,medicine ,Leprosy ,Restriction fragment length polymorphism ,Mycobacterium leprae ,Genotyping ,030217 neurology & neurosurgery ,Genetics (clinical) ,Polymerase chain reaction - Abstract
Background Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae , the obligate intracellular bacillus that attacks cutaneous tissue and can damage the peripheral nervous system. Aim To determine the association between the Ninjurin 1 gene asp110ala (rs2275848) polymorphism in nerve damage leprosy patients. Meterials and methods We carried the 234 leprosy patients along with equal number of controls with age and gender-matched were recruited. Genotyping was done by polymerase chain reaction/restriction fragment length polymorphism and confirmation of sequence. Results The CC genotype (ala/ala) had a higher risk of developing nerve disability when compared those carrying the AA genotype (asp/asp) and the variation observed were statistically significant at P Conclusion The Ninjurin 1 gene asp110ala genetic variation may be a risk of nerve damage among leprosy patients in south India.
- Published
- 2017
- Full Text
- View/download PDF